Financial Results For The Quarter Ended 30Th September, 2026.
Filed with BSE · ISIN INE194R01017 · · 15 pages · English
In furtherance to the intimation filed by the Company dated November 28, 2026 the trading window for trading in securities of the Company by insiders closed on October 01, 2026 till the end of 48 hours after the declaration of outcome of this Board Meeting. The Board Meeting commenced at 10:00 a.m. and concluded at 11:10 a.m. Kindly oblige and take the same on your Records. FREDUN NARIMAN MEDHORA
Fredun Pharmaceuticals Ltd. on 6ix
Earlier from Fredun Pharmaceuticals
- Board Meeting Outcome for Outcome Of The Board Meeting
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Announcement under Regulation 30 (LODR)-Allotment
- Revised Outcome Of Board Meeting Dated 03Rd October, 2026.
Later from Fredun Pharmaceuticals
- Approved The Proposal For Making An Application To National Stock Exchange Of India Limited (NSE) For Listing And Trading Of The Equity Shares Of The Company On NSE.
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Follow Fredun Pharmaceuticals into a list and get an email when it puts out news.
Follow Fredun Pharmaceuticals